Patents by Inventor Christopher Winter

Christopher Winter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250147340
    Abstract: A computer-implemented method of determining a base curve value representing a base curve for a front surface of a spectacle lens is disclosed. The method includes receiving individual prescription data and determining the base curve value for the front surface of the spectacle lens based on the prescription data. In particular, the base curve value is calculated from the received prescription data based on a functional relationship between one or more values included in the prescription data and the base curve value.
    Type: Application
    Filed: January 9, 2025
    Publication date: May 8, 2025
    Applicant: Carl Zeiss Vision International GmbH
    Inventors: Markus Welscher, Helmut Wietschorke, Ralf-Roland Sauer, Christoph Winter
  • Patent number: 12228803
    Abstract: A computer-implemented method of determining a base curve value representing a base curve for a front surface of a spectacle lens is disclosed. The method includes receiving individual prescription data and determining the base curve value for the front surface of the spectacle lens based on the prescription data. In particular, the base curve value is calculated from the received prescription data based on a functional relationship between one or more values included in the prescription data and the base curve value.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: February 18, 2025
    Assignee: Carl Zeiss Vision International GmbH
    Inventors: Markus Welscher, Helmut Wietschorke, Ralf-Roland Sauer, Christoph Winter
  • Publication number: 20250026821
    Abstract: The invention provides an improved pan-TGF-? antibody for treatment of conditions that are mediated by TGF-?, including autoimmune diseases, fibrotic conditions, and cancers. Also provided are methods and uses of the antibody in conjunction with other immunomodulatory agents such as an anti-PD-1 antibody.
    Type: Application
    Filed: July 9, 2024
    Publication date: January 23, 2025
    Applicant: SANOFI
    Inventors: Gary Shapiro, Kevin Brower, Patrick Finn, Richard C. Gregory, Rao Koduri, Feng Liu, Natalia Malkova, Parminder Mankoo, Jack R. Pollard, Huawei Qiu, Joachim Theilhaber, Christopher Winter, Marcella Yu
  • Patent number: 12049496
    Abstract: The invention provides an improved pan-TGF-? antibody for treatment of conditions that are mediated by TGF-?, including autoimmune diseases, fibrotic conditions, and cancers. Also provided are methods and uses of the antibody in conjunction with other immunomodulatory agents such as an anti-PD-1 antibody.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: July 30, 2024
    Assignee: Sanofi
    Inventors: Gary Shapiro, Kevin Brower, Patrick Finn, Richard C. Gregory, Rao Koduri, Feng Liu, Natalia Malkova, Parminder Mankoo, Jack R. Pollard, Huawei Qiu, Joachim Theilhaber, Christopher Winter, Marcella Yu
  • Publication number: 20230358577
    Abstract: A detection device may be attached to or secured in a vehicle component, with which physical and/or chemical values can be detected. The device may include of at least one of the following: a detection unit placed or formed on a first mount for detecting a physical and/or chemical value, wherein the first mount has at least one mounting interface for attaching the first mount to the vehicle component; and a functional unit to which the detection unit is dedicated, placed or formed on or in a second mount, wherein the second mount has at least one connecting interface for connecting the second mount to the first mount.
    Type: Application
    Filed: September 10, 2021
    Publication date: November 9, 2023
    Applicant: ZF Friedrichshafen AG
    Inventors: Philipp Lang, Martin Hermann, Michael Schwab, Christopher Winter, Thomas Stauderer, Ulrich Mair
  • Publication number: 20220195026
    Abstract: The invention provides an improved pan-TGF-? antibody for treatment of conditions that are mediated by TGF-?, including autoimmune diseases, fibrotic conditions, and cancers. Also provided are methods and uses of the antibody in conjunction with other immunomodulatory agents such as an anti-PD-1 antibody.
    Type: Application
    Filed: December 23, 2021
    Publication date: June 23, 2022
    Applicant: SANOFI
    Inventors: Gary Shapiro, Kevin Brower, Patrick Finn, Richard C. Gregory, Rao Koduri, Feng Liu, Natalia Malkova, Parminder Mankoo, Jack R. Pollard, Huawei Qiu, Joachim Theilhaber, Christopher Winter, Marcella Yu
  • Patent number: 11242384
    Abstract: The invention provides an improved pan-TGF-? antibody for treatment of conditions that are mediated by TGF-?, including autoimmune diseases, fibrotic conditions, and cancers. Also provided are methods and uses of the antibody in conjunction with other immunomodulatory agents such as an anti-PD-1 antibody.
    Type: Grant
    Filed: July 16, 2020
    Date of Patent: February 8, 2022
    Assignee: SANOFI
    Inventors: Gary Shapiro, Kevin Brower, Patrick Finn, Richard C. Gregory, Rao Koduri, Feng Liu, Natalia Malkova, Parminder Mankoo, Jack R. Pollard, Huawei Qiu, Joachim Theilhaber, Christopher Winter, Marcella Yu
  • Publication number: 20200409985
    Abstract: Methods and apparatus, including computer program products, implementing and using techniques for converting a target file into a multimedia presentation. A target file including text is received. A class of the target file is identified based on characteristics of the target file. A multimedia presentation is created that contains speech rendered from a portion of the text, additional text, wherein the portion of the text is selected in accordance with a template programmed with content and logic for the identified class, a visual representation of the document, and one or more manipulations of the visual representation defined in accordance with the content and logic of the template. In response to a user command to run the multimedia presentation, the speech, visual representation, and/or the manipulations are output in accordance with the logic of the template.
    Type: Application
    Filed: May 29, 2020
    Publication date: December 31, 2020
    Inventors: William Robert Nelson, Joshua Michael Huntington, Scott Christopher Winters
  • Publication number: 20200399358
    Abstract: The invention provides an improved pan-TGF-? antibody for treatment of conditions that are mediated by TGF-?, including autoimmune diseases, fibrotic conditions, and cancers. Also provided are methods and uses of the antibody in conjunction with other immunomodulatory agents such as an anti-PD-1 antibody.
    Type: Application
    Filed: July 16, 2020
    Publication date: December 24, 2020
    Inventors: Gary Shapiro, Kevin Brower, Patrick Finn, Richard C. Gregory, Rao Koduri, Feng Liu, Natalia Malkova, Parminder Mankoo, Jack R. Pollard, Huawei Qiu, Joachim Theilhaber, Christopher Winter, Marcella Yu
  • Patent number: 10841472
    Abstract: The present invention relates to a method for controlling a lighting device, the method comprising: receiving data relating to settings on a camera; determining an illuminance for at least one lighting device in dependence on said data; and modifying the illuminance of a lighting device to said determined illuminance.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: November 17, 2020
    Assignee: Rotolight Limited
    Inventors: Roderick Allen Gammons, Jan Christoph Winter, Andrew Francis, Roderick Aaron Gammons
  • Patent number: 10766955
    Abstract: The invention provides an improved pan-TGF-? antibody for treatment of conditions that are mediated by TGF-?, including autoimmune diseases, fibrotic conditions, and cancers. Also provided are methods and uses of the antibody in conjunction with other immunomodulatory agents such as an anti-PD-1 antibody.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: September 8, 2020
    Assignee: SANOFI
    Inventors: Gary Shapiro, Kevin Brower, Patrick Finn, Richard C. Gregory, Rao Koduri, Feng Liu, Natalia Malkova, Parminder Mankoo, Jack R. Pollard, Huawei Qiu, Joachim Theilhaber, Christopher Winter, Marcella Yu
  • Publication number: 20200050020
    Abstract: A computer-implemented method of determining a base curve value representing a base curve for a front surface of a spectacle lens is disclosed. The method includes receiving individual prescription data and determining the base curve value for the front surface of the spectacle lens based on the prescription data. In particular, the base curve value is calculated from the received prescription data based on a functional relationship between one or more values included in the prescription data and the base curve value.
    Type: Application
    Filed: October 18, 2019
    Publication date: February 13, 2020
    Inventors: Markus Welscher, Helmut Wietschorke, Ralf-Roland Sauer, Christoph Winter
  • Publication number: 20190192522
    Abstract: Described herein are selective inhibitors of FGFR4, pharmaceutical compositions including such compounds, and combinations with other therapeutic agents, such as CDK inhibitors (e.g., CDK4/6 inhibitors), and methods of using such combinations.
    Type: Application
    Filed: September 8, 2017
    Publication date: June 27, 2019
    Applicant: BLUEPRINT MEDICINES CORPORATION
    Inventors: Margit HAGEL, Klaus HOEFLICH, Christoph LENGAUER, Nicolas STRANSKY, Christopher WINTER, Lan XU
  • Publication number: 20180307058
    Abstract: A computer implemented method of determining a base curve value representing a base curve for a front surface of a spectacle lens comprises the steps of receiving individual prescription data and determining the base curve value for the front surface of the spectacle lens based on the prescription data. The base curve value is calculated from the received prescription data based on a functional relationship between one or more values included in the prescription data and the base curve value.
    Type: Application
    Filed: April 21, 2017
    Publication date: October 25, 2018
    Inventors: Markus Welscher, Helmut Wietschorke, Ralf-Roland Sauer, Christoph Winter
  • Publication number: 20180244763
    Abstract: The invention provides an improved pan-TGF-? antibody for treatment of conditions that are mediated by TGF-?, including autoimmune diseases, fibrotic conditions, and cancers. Also provided are methods and uses of the antibody in conjunction with other immunomodulatory agents such as an anti-PD-1 antibody.
    Type: Application
    Filed: January 19, 2018
    Publication date: August 30, 2018
    Applicant: SANOFI
    Inventors: Gary Shapiro, Kevin Brower, Patrick Finn, Richard C. Gregory, Rao Koduri, Feng Liu, Natalia Malkova, Parminder Mankoo, Jack R. Pollard, Huawei Qiu, Joachim Theilhaber, Christopher Winter, Marcella Yu
  • Patent number: 10007128
    Abstract: A device and a method for establishing a target design are disclosed. A generator generates a graphical representation of a starting target design and displays it on a display. A user directly manipulates a graphical representation of the starting target design displayed on the display through the graphical user interface. The graphical representation of the manipulated starting target design is updated and displayed on the display.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: June 26, 2018
    Assignee: Carl Zeiss Vision International GmbH
    Inventors: Markus Welscher, Ralf-Roland Sauer, Christoph Winter, Ray Steven Spratt
  • Publication number: 20170374250
    Abstract: The present invention relates to a method for controlling a lighting device, the method comprising: receiving data relating to settings on a camera; determining an illuminance for at least one lighting device in dependence on said data; and modifying the illuminance of a lighting device to said determined illuminance.
    Type: Application
    Filed: April 7, 2017
    Publication date: December 28, 2017
    Inventors: Roderick Allen GAMMONS, Jan Christoph WINTER, Andrew FRANCIS, Roderick Aaron GAMMONS
  • Patent number: 9233326
    Abstract: A separating device for separating a multiphase medium includes a cyclone separating device (1) that provokes an at least partial distribution of at least two phases of the medium with the formation of a vortex flow for the medium. Each phase having a lower density compared to the other phase is separated from the other phase and can be guided out of the separating device by a collecting device (35, 37).
    Type: Grant
    Filed: September 28, 2011
    Date of Patent: January 12, 2016
    Assignee: HYDAC PROCESS TECHNOLOGY GMBH
    Inventors: Bernhard Schlichter, Ralf Wnuk, Thomas Böttcher, Christoph Winter, Klaus Kimmerle
  • Patent number: 9110082
    Abstract: The present invention relates to methods for treating a dalotuzumab responsive cancer, in a patient, comprising determining the expression level of liver kinase B1 (LKB1), in a cancer cell from the patient, and when said expression is determined to be lower than that of a control cell; administering, to said patient, a therapeutically effective amount of dalotuzumab. The invention also relates to methods for assessing neoplastic cells, selecting patients, selecting therapies as well as diagnostic methods.
    Type: Grant
    Filed: November 22, 2010
    Date of Patent: August 18, 2015
    Assignee: MERCK SHARP & DOHME CORP.
    Inventors: Sriram Sathyanarayanan, Christopher Winter, Youyuan Xu
  • Patent number: 8852590
    Abstract: A method of treating a cancer with an mTOR inhibitor and an anti-IGF-1 R antibody is disclosed.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: October 7, 2014
    Assignees: Merck Sharp & Dohme Corp., Ariad Pharmaceuticals, Inc.
    Inventors: Sriram Sathyanarayanan, Christopher Winter, Richard Klinghoffer